Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelis Boersma

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Expert Review of Clinical Pharmacology|December 7, 2011
Flexibility of Markov modeling for clinical pharmacoeconomics: illustration for cost-effectiveness in early Parkinson's diseaseMaarten J Postma, Cornelis Boersma
Journal of the National Cancer Institute|March 16, 2010
Response: Re: Cost-effectiveness analysis of human papillomavirus vaccination in the NetherlandsMark Hermannes Rozenbaum, Cornelis Boersma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Health Economics of Vaccines: From Current Practice to Future PerspectivesCornelis Boersma, Maarten J Postma
The Journal of Infectious Diseases|December 22, 2021
Reply to Anglemyer et alFlorian Zeevat, Cornelis Boersma, Maarten Postma
Frontiers in Pharmacology|June 6, 2022
Critical Reflections on Reimbursement and Access of Advanced TherapiesSteven Simoens, Katrien De Groote, Cornelis Boersma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 9, 2010
Quantification of the potential impact of cost-effectiveness thresholds on dutch drug expenditures using retrospective analysisCornelis Boersma, Adriaan Broere, Maarten J Postma
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2007
Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuriaMaarten J Postma, Cornelis Boersma, Ron T Gansevoort
Expert Review of Vaccines|August 8, 2020
The potential impact of COVID-19 pandemic on the immunization performance in IndonesiaAuliya A Suwantika, Cornelis Boersma, Maarten J Postma
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 14, 2024
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the NetherlandsSimon van der Pol, Maarten J Postma, Cornelis Boersma
JMIR Cardio|May 9, 2025
Prerequisites for Cost-Effective Home Blood Pressure Telemonitoring: Early Health Economic AnalysisJob van Steenkiste, Pim van Dorst, Daan Dohmen, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Expert Review of Clinical Pharmacology|December 7, 2011
Flexibility of Markov modeling for clinical pharmacoeconomics: illustration for cost-effectiveness in early Parkinson's diseaseMaarten J Postma, Cornelis Boersma
Journal of the National Cancer Institute|March 16, 2010
Response: Re: Cost-effectiveness analysis of human papillomavirus vaccination in the NetherlandsMark Hermannes Rozenbaum, Cornelis Boersma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Health Economics of Vaccines: From Current Practice to Future PerspectivesCornelis Boersma, Maarten J Postma
The Journal of Infectious Diseases|December 22, 2021
Reply to Anglemyer et alFlorian Zeevat, Cornelis Boersma, Maarten Postma
Frontiers in Pharmacology|June 6, 2022
Critical Reflections on Reimbursement and Access of Advanced TherapiesSteven Simoens, Katrien De Groote, Cornelis Boersma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 9, 2010
Quantification of the potential impact of cost-effectiveness thresholds on dutch drug expenditures using retrospective analysisCornelis Boersma, Adriaan Broere, Maarten J Postma
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2007
Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuriaMaarten J Postma, Cornelis Boersma, Ron T Gansevoort
Expert Review of Vaccines|August 8, 2020
The potential impact of COVID-19 pandemic on the immunization performance in IndonesiaAuliya A Suwantika, Cornelis Boersma, Maarten J Postma
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 14, 2024
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the NetherlandsSimon van der Pol, Maarten J Postma, Cornelis Boersma
JMIR Cardio|May 9, 2025
Prerequisites for Cost-Effective Home Blood Pressure Telemonitoring: Early Health Economic AnalysisJob van Steenkiste, Pim van Dorst, Daan Dohmen, et al.
Pageof 9